Date | Time | Source | Announcement |
---|---|---|---|
06 Jul 2006 | 07:00 AM | Pfizer Products Acquisition | |
08 Jun 2006 | 07:00 AM | Appointment | |
22 May 2006 | 07:00 AM | Distribution Agreement | |
18 May 2006 | 02:43 PM | Major Interests in Shares | |
18 May 2006 | 07:00 AM | Dermatology Acquisition | |
17 May 2006 | 07:00 AM | Notification of Interests | |
12 May 2006 | 10:19 AM | AGM Statement | |
10 May 2006 | 07:00 AM | Placing to raise GBP2.5m | |
23 Mar 2006 | 07:01 AM | Preliminary Results | |
21 Mar 2006 | 02:07 PM | Interest in Major Shares | |
02 Mar 2006 | 07:00 AM | Notice of Results | |
09 Feb 2006 | 01:05 PM | Hydromol Acquisition | |
10 Jan 2006 | 07:00 AM | Trading Statement | |
03 Nov 2005 | 07:00 AM | Interim Results | |
03 Nov 2005 | 07:00 AM | Product Disposal | |
11 Oct 2005 | 11:21 AM | Results Notification | |
01 Aug 2005 | 07:00 AM | Notification of Shares | |
29 Jul 2005 | 07:00 AM | Distribution Agreement | |
13 Jul 2005 | 10:11 AM | Notification of Shares | |
06 Jul 2005 | 07:00 AM | Phase III Trials Approval | |
24 Jun 2005 | 07:00 AM | Notice of Interests in Shares | |
21 Jun 2005 | 10:52 AM | AGM Statement | |
17 May 2005 | 07:00 AM | Share Purchase | |
16 May 2005 | 12:35 PM | Director Share Dealing | |
12 May 2005 | 07:00 AM | Preliminary Results | |
11 May 2005 | 09:55 AM | Share Purchase | |
09 May 2005 | 07:00 AM | Co-Promotion Agreement | |
30 Mar 2005 | 05:33 PM | Holding(s) in Company | |
16 Mar 2005 | 07:00 AM | Trading Statement | |
28 Feb 2005 | 11:37 AM | Director Shareholding | |
11 Jan 2005 | 07:00 AM | Clinical Trial Commences | |
17 Nov 2004 | 07:00 AM | Re Agreement | |
16 Nov 2004 | 10:28 AM | Director Shareholding | |
11 Nov 2004 | 06:30 PM | Holding(s) in Company | |
10 Nov 2004 | 10:02 AM | Nigel Wray acquires shares | |
22 Oct 2004 | 07:15 AM | Acquisition | |
22 Oct 2004 | 07:15 AM | Interim Results | |
20 Aug 2004 | 07:00 AM | Loan Note Payment | |
28 Jul 2004 | 07:00 AM | Options Granted | |
15 Jun 2004 | 12:00 PM | AGM Statement | |
12 May 2004 | 07:00 AM | Final Results | |
26 Apr 2004 | 08:00 AM | Notice of Results | |
10 Mar 2004 | 07:00 AM | Trading Statement | |
19 Feb 2004 | 12:03 PM | Director Shareholding | |
19 Feb 2004 | 12:01 PM | Directorate Change | |
12 Feb 2004 | 04:33 PM | Loan Stock Interest Payment | |
10 Feb 2004 | 07:00 AM | Acquisition | |
06 Feb 2004 | 09:52 AM | Directorate Change | |
22 Dec 2003 | 12:35 PM | Result of EGM | |
22 Dec 2003 | 07:00 AM | Result of Open Offer |
Alliance Pharma markets prescription medicines and consumer healthcare products, including Nizoral™ anti-dandruff shampoo and KELO-COTE™ silicone scar treatment.
It operated in 100 countries, including the UK, Ireland, Mainland Europe, the British Virgin Islands, France, the US, and Germany.
Alliance share price launched at 51p in 2001.